Antibody data
- Antibody Data
- Antigen structure
- References [8]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- FAB3481P - Provider product page
- Provider
- Novus Biologicals
- Product name
- Mouse Monoclonal ErbB3/Her3 Antibody
- Antibody type
- Monoclonal
- Antigen
- Mouse myeloma cell line NS0-derived recombinant human ErbB3/Her3, corresponding to Ser20-Thr643
- Reactivity
- Human
- Host
- Mouse
- Conjugate
- Yellow dye
- Isotype
- IgG
- Vial size
- 100 Tests
- Storage
- Store at 4°C in the dark.
Submitted references Simultaneous targeting of EGFR, HER2, and HER4 by afatinib overcomes intrinsic and acquired cetuximab resistance in head and neck squamous cell carcinoma cell lines.
Uniting the neurodevelopmental and immunological hypotheses: Neuregulin 1 receptor ErbB and Toll-like receptor activation in first-episode schizophrenia.
Paracrine Effect of NRG1 and HGF Drives Resistance to MEK Inhibitors in Metastatic Uveal Melanoma.
Phenotyping of human melanoma cells reveals a unique composition of receptor targets and a subpopulation co-expressing ErbB4, EPO-R and NGF-R.
The MAPK pathway is a predominant regulator of HLA-A expression in esophageal and gastric cancer.
HER3 targeting of adenovirus by fiber modification increases infection of breast cancer cells in vitro, but not following intratumoral injection in mice.
Protein secretion in human mammary epithelial cells following HER1 receptor activation: influence of HER2 and HER3 expression.
Signaling of ERBB receptor tyrosine kinases promotes neuroblastoma growth in vitro and in vivo.
De Pauw I, Lardon F, Van den Bossche J, Baysal H, Fransen E, Deschoolmeester V, Pauwels P, Peeters M, Vermorken JB, Wouters A
Molecular oncology 2018 Jun;12(6):830-854
Molecular oncology 2018 Jun;12(6):830-854
Uniting the neurodevelopmental and immunological hypotheses: Neuregulin 1 receptor ErbB and Toll-like receptor activation in first-episode schizophrenia.
Kéri S, Szabó C, Kelemen O
Scientific reports 2017 Jun 23;7(1):4147
Scientific reports 2017 Jun 23;7(1):4147
Paracrine Effect of NRG1 and HGF Drives Resistance to MEK Inhibitors in Metastatic Uveal Melanoma.
Cheng H, Terai M, Kageyama K, Ozaki S, McCue PA, Sato T, Aplin AE
Cancer research 2015 Jul 1;75(13):2737-48
Cancer research 2015 Jul 1;75(13):2737-48
Phenotyping of human melanoma cells reveals a unique composition of receptor targets and a subpopulation co-expressing ErbB4, EPO-R and NGF-R.
Mirkina I, Hadzijusufovic E, Krepler C, Mikula M, Mechtcheriakova D, Strommer S, Stella A, Jensen-Jarolim E, Höller C, Wacheck V, Pehamberger H, Valent P
PloS one 2014;9(1):e84417
PloS one 2014;9(1):e84417
The MAPK pathway is a predominant regulator of HLA-A expression in esophageal and gastric cancer.
Mimura K, Shiraishi K, Mueller A, Izawa S, Kua LF, So J, Yong WP, Fujii H, Seliger B, Kiessling R, Kono K
Journal of immunology (Baltimore, Md. : 1950) 2013 Dec 15;191(12):6261-72
Journal of immunology (Baltimore, Md. : 1950) 2013 Dec 15;191(12):6261-72
HER3 targeting of adenovirus by fiber modification increases infection of breast cancer cells in vitro, but not following intratumoral injection in mice.
MacLeod SH, Elgadi MM, Bossi G, Sankar U, Pisio A, Agopsowicz K, Sharon D, Graham FL, Hitt MM
Cancer gene therapy 2012 Dec;19(12):888-98
Cancer gene therapy 2012 Dec;19(12):888-98
Protein secretion in human mammary epithelial cells following HER1 receptor activation: influence of HER2 and HER3 expression.
Zhang Y, Gonzalez RM, Zangar RC
BMC cancer 2011 Feb 14;11:69
BMC cancer 2011 Feb 14;11:69
Signaling of ERBB receptor tyrosine kinases promotes neuroblastoma growth in vitro and in vivo.
Richards KN, Zweidler-McKay PA, Van Roy N, Speleman F, Trevino J, Zage PE, Hughes DP
Cancer 2010 Jul 1;116(13):3233-43
Cancer 2010 Jul 1;116(13):3233-43
No comments: Submit comment
No validations: Submit validation data